<DOC>
	<DOCNO>NCT00633568</DOCNO>
	<brief_summary>The purpose present trial ass induction concurrent chemoradiotherapy follow consolidation chemotherapy improve survival comparison chemotherapy give induction follow consolidation concurrent chemoradiotherapy .</brief_summary>
	<brief_title>Randomised Study Concomitant Radiochemotherapy Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histological cytological diagnosis nonsmall cell carcinoma lung Initially unresectable nonmetastatic stage III disease Availability participate detailed followup protocol Presence evaluable measurable lesion Written inform consent No functional anatomical contraindication chest irradiation Prior treatment chemotherapy , radiotherapy surgery Performance status &lt; 60 Karnofsky scale History prior malignant tumour , except nonmelanoma skin cancer situ carcinoma cervix cure malignant tumour ( 5 year diseasefree interval ) Neutrophils &lt; 2,000/mm³ Platelet cell &lt; 100,000/mm3 Serum bilirubin &gt; 1.5 mg/100 ml Hepatic disease contraindicate administration docetaxel and/or GOT GPT ≥ 2.5x normal value and/or alkaline phosphatase ≥ 5x normal value Serum creatinine &gt; 1.5 mg/100 ml and/or creatinine clearance &lt; 60 ml/min Recent myocardial infarction ( le 3 month prior date diagnosis ) uncontrolled angina pectoris Congestive cardiac failure cardiac arrhythmia require medical treatment Uncontrolled infectious disease Symptomatic polyneuropathy Auditive impairment contraindicate cisplatin administration Serious medical psychological factor may prevent adherence treatment schedule Malignant pleural pericardial effusion Homolateral supraclavicular lymph node except upper lobe lesion Heterolateral supraclavicular lymph node Known hypersensitivity docetaxel cisplatin Pregnancy premenopausal patient , incapacity use adequate contraceptive method</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Non-small cell lung carcinoma</keyword>
	<keyword>Concomitant radiochemotherapy</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>Docetaxel</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Unresectable stage III non-small cell lung carcinoma</keyword>
</DOC>